Sort by
Refine Your Search
-
Employer
- University of Oxford
- King's College London
- Queen Mary University of London
- University of Oxford;
- The University of Edinburgh;
- Queen Mary University of London;
- University of Liverpool
- AALTO UNIVERSITY
- DURHAM UNIVERSITY
- UNIVERSITY OF VIENNA
- University of Cambridge;
- University of Dundee;
- Durham University
- Heriot Watt University
- Imperial College London
- Liverpool School of Tropical Medicine;
- Lund University
- Oxford Brookes University
- University of Cambridge
- University of Leeds
- University of Lincoln
- University of London
- University of Newcastle
- University of West London
- University of York
- 15 more »
- « less
-
Field
-
al. Nature Genetics 2020, Costea et al. and Schoeberl et al., Mol Cell 2023, Mol Cell 2025). For a list of ongoing projects and publications, please visit: https://www.kcl.ac.uk/research/pavri-group
-
research programme with two main strands: (i) bioinformatics experiments to unravel the genetic basis of cardiovascular diseases and discover novel therapeutic targets, including genome-wide association
-
research programme with two main strands: (i) bioinformatics experiments to unravel the genetic basis of cardiovascular diseases and discover novel therapeutic targets, including genome-wide association
-
to shape infection outcomes. Using the genetically tractable model organism Drosophila melanogaster, this project will determine how infection-induced triglyceride mobilisation influences survival and why
-
to shape infection outcomes. Using the genetically tractable model organism Drosophila melanogaster, this project will determine how infection-induced triglyceride mobilisation influences survival and why
-
of DNAAF9 (axonemal dynein assembly factor 9) in ciliary biology. This will involve CRISPR genetic engineering using relevant ciliated cell lines to knockout DNAAF9 followed by cytological, proteomic and
-
, and use genetic screening approaches to characterise novel nuclear modifiers of disease progression. The focus of your work will be on studying how nuclear and mitochondrial DNA defects lead to tissue
-
, the postholder will establish mosaic organoid models containing apoptosis-prone and apoptosis-resistant neurons, and integrate iPSC-derived microglia from defined genetic backgrounds, including APOE3/3 and APOE4/4
-
-prone and apoptosis-resistant neurons, and integrate iPSC-derived microglia from defined genetic backgrounds, including APOE3/3 and APOE4/4 lines. The work will combine live imaging, single-cell RNA
-
with Nuffield Department of Clinical Neuroscience (NDCN), Nuffield Department of Population Health (NDPH) and Department of Physiology, Anatomy and Genetics (DPAG). The Institute brings together the very